Pre-Illness Isoflavone Consumption and Disease Risk of Ulcerative Colitis: A Multicenter Case-Control Study in Japan

• Satoko Ohfuji ,

  * E-mail: satop@med.osaka-cu.ac.jp

  ¶SO is the lead author for the Study Group on this work.

  Affiliation Department of Public Health, Osaka City University Faculty of Medicine, Osaka, Japan

  ⨯
• Wakaba Fukushima,

  Affiliation Department of Public Health, Osaka City University Faculty of Medicine, Osaka, Japan

  ⨯
• Kenji Watanabe,

  Affiliation Department of Gastroenterology, Osaka City University Faculty of Medicine, Osaka, Japan

  ⨯
• Satoshi Sasaki,

  Affiliation Department of Social and Preventive Epidemiology, School of Public Health, The University of Tokyo, Tokyo, Japan

  ⨯
• Hirokazu Yamagami,

  Affiliation Department of Gastroenterology, Osaka City University Faculty of Medicine, Osaka, Japan

  ⨯
• Masakazu Nagahori,

  Affiliation Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Mamoru Watanabe,

  Affiliation Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Yoshio Hirota,

  Affiliations Department of Public Health, Osaka City University Faculty of Medicine, Osaka, Japan, Clinical Epidemiology Research Center, Medical Co. LTA, Fukuoka, Japan

  ⨯
• for the Japanese Case-Control Study Group for Ulcerative Colitis

  ¶‡ Other members of the Japanese Case-Control Study Group for Ulcerative Colitis are listed in the Acknowledgments.

  ⨯